Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 June, 2018 00:55 IST
Indoco Remedies gets 8 USFDA observations for its Goa unit
Source: IRIS | 14 Feb, 2018, 10.09AM
Comments  |  Post Comment

Indoco Remedies has informed that USFDA inspected its solid dosage plant in Goa (Unit I). At the end of the inspection, the plant has received 8 observations (483s). The filling indicates that all the observations are correctable and the company is in the process of preparing its response for the same.

Exports from Goa solid dosage plant constitute less than 10% of the Indoco’s total exports and less than 4% of the total sales.

Shares of the company declined Rs 6.45, or 2.33%, to trade at Rs 269.90. The total volume of shares traded was 7,323 at the BSE (9.59 a.m., Wednesday).





Indoco Remedies Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
NHPC signs PPA with UPPCL for Kishanganga project - 25-Jun-2018 16:47
Info Edge enters into agreement with Soft Bank for joint investment - 25-Jun-2018 16:43
Ratnamani Metals & Tubes receives order worth Rs 1.25 bn - 25-Jun-2018 16:38
Jet Airways to acquire 75 Boeing 737 MAX Aircrafts - 25-Jun-2018 16:35
MCX signs MoU with IMC to Synergise Efforts - 25-Jun-2018 16:16
Voltas JV lays ground to build 1st manufacturing unit - 25-Jun-2018 12:37
Vikas Ecotech to set up India's First 2-EHTG unit in Dahej - 25-Jun-2018 12:24
MBL Infra substantially completes two projects - 25-Jun-2018 12:19
Tata Comm partners with Singapore based IoT star-up W-Locate - 25-Jun-2018 10:26
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer